2BBBullish & Bearish
Health Care

ImmuCell Corporation (ICCC) Stock Score & Signals

ImmuCell Corporation (ICCC) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 27 out of 100.

2BB score and signals

ImmuCell Corporation’s current 2BB score is 27 out of 100, built from the signal categories below.

SignalScoreReading
Activity18Very Low
Momentum50Stable
Financial strength68Strong
Quality80Very Strong
Risk32Low

Company facts

CEOMichael F Brigham
HeadquartersPortland, Maine, United States
Founded1982
Employees73
P/E ratio128.16
52-week range$4.52 – $12.10

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-03-02————
2026-11-11————
2026-08-13————
2026-05-140.21—$10.36M—